SUBSITE CONCEPT FOR METASTASES IN CLINICAL STAGE I MELANOMA
- 1 July 1982
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 320 (8290) , 154
- https://doi.org/10.1016/s0140-6736(82)91116-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patientsBritish Journal of Surgery, 1982
- Regional Differences in the Growth of Normal and Neoplastic CellsScience, 1982
- Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and MetastasisAnnals of Surgery, 1982
- Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV LesionsAnnals of Surgery, 1982
- A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models*Annals of Surgery, 1982
- The Natural Break Points for Primary-Tumor Thickness in Clinical Stage I MelanomaNew England Journal of Medicine, 1981
- A prognostic model for clinical stage I melanoma of the trunkThe American Journal of Surgery, 1981
- The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical CorrelationsBritish Journal of Haematology, 1981
- A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent DiseaseAnnals of Surgery, 1981
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970